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1. Introduction 
Ornithine decarboxylase (EC 4.1.1.17) which 
catalyzes the conversion of ornithine to putrescine, 
the rate-limiting step in the biosynthesis of the 
polyamines [l-5], is known to play a key role in the 
control of cell growth, proliferation and differentia- 
tion [6--91. Therefore, the regulatory mechanism of
its activity is of particular interest. The existence of 
inhibitor proteins was initially demonstrated in rat 
hepatoma cells [ 10,l l] and has been amply verified 
in animal cells, cultured cells and Escherichia culi [9]. 
A nondialyzable activator has also been demonstrated 
in E. co& [ 121, suggest~g the existence of a post- 
tr~~ational regulatory mech~ism of the activity of 
ornithine decarboxylase. Here, the activity of orni- 
thine decarboxylase is reported to be inhibited by 
polyanions including a naturally occurring polyanion 
such as heparin, presumably owing to a direct interac- 
tion of polyanions and the enzyme protein. The inter- 
action of heparin and the enzyme was prevented by 
the addition of salts. 
2. Materials and methods 
D,L- [ 1 -“4C] Ornithine (58 mCi/mmol) was pur- 
chased from Radiochemical Centre, Amersham. DE-52 
was from Whatman Biochemicals. Sepharose 4B and 
dextran sulfate were obtained from Pharmacia Fine 
Chemicals. Poly(Lglutamic acid) (type II-B), poly(L 
lysine) (type I-B), DNA (type I), RNA (type XI) and 
bovine serum albumin were from Sigma Chemical Co. 
Ornithine decarboxylase was purified -150.fold 
with a 30% yield from the liver cytosol of the rats 
which had been treated with thioacetamide (131 
using acid treatment, ~monium sulfate fractionation, 
acetone fractionation and chromato~aphy on DE-52. 
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Enzyme activity was determined by measurement of 
the rate of i4C02 evolution from L[l-‘4C]ornithine. 
The assay mixture contained, in 0.5 ml final vol.: 
50 mM sodium phosphate buffer (pH 7.0) 0.1 mM 
pyridoxal phosphate, 5mM dithiothreitol, 0.6 mM 
L-ornithine and a suitable amount of the enzyme 
solution. The reaction was carried out at 37°C for 1 h 
with shaking. The reaction was stopped by the addi- 
tion of 0.4 ml 8% perchloric acid and the 14C02 
evolved was determined essentially as in [ 141. 
Protein concentration was determined as in [ 151 
with bovine serum albumin as a standard. 
Hepa~n-substituted Sepharose 4B was prepared as 
in [16]. 
3. Results and discussion 
Fig.1 shows the inhibitory effect of heparin on the 
activity of ornithine decarboxylase. In the presence 
of increasing amounts of heparin, the activity of orni- 
thine decarboxylase was progressively inhibited. 
Similar inhibition of the enzyme was observed to 
occur by the addition of other polyanions uch as 
~ly(~lu) and dextran sulfate, although poly(L 
Lys), a polycation, showed no signi~c~t i~ibition 
of the enzyme as shown in table 1. DNA and RNA 
also appeared to elicit a slight inhibition of the 
enzyme. 
The inhibition of the enzyme by heparin and 
dextran sulfate was prevented by 0.15 M NaCl, sug- 
gesting that electrostatic forces may be implicated in 
this inhibition. To examine whether the inhibition of 
the enzyme by heparin occurred as a result of a direct 
interaction between the enzyme and heparin or not, 
the interaction of ornithine decarboxylase with immo- 
bilized heparin was studied as shown in fig.2. When a 
partially purified preparation of omithine decarboxyl- 
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Fig.1. Effect of increasing concentrations of heparln on the 
inhibition of the activity of ornithine decarboxylase. The 
activity of ornithine decarboxylase (55.9 ng protein) was 
measured as in section 2 but in the presence of the indicated 
amounts of heparin. 
ase was applied to a column of heparin-substituted 
Sepharose, X5% of the enzyme activity was bound 
to the column. After washing with 25 mM NaCl in 
10 mM sodium phosphate buffer (pH 7.0) containing 
0.1 mM EDTA, 10 mM 2-mercaptoethanol and 0.1 mM 
pyridoxal phosphate, -90% of the total activity was 
eluted with NaCl at the same level (0.15 M) as that at 
which the inhibition of the enzyme by heparin was 
prevented by NaCl, suggesting that the inhibition may 
result from a direct interaction of the enzyme with 
heparin and furthermore suggesting that the inhibition 
Table 1 
Inhibition of ornithine decarboxylase activity by polyanions 
Additions Enzyme activity 
(nmol WO, evolved) (%) 
None 7.30 (100) 
Heparin (2 mg/ml) 1.24 ( 17) 
Poly(LGlu) (2 mg/ml) 0.15 ( 2) 
Dextran sulfate (2 mg/ml) 0.60 ( 8) 
Poly(L-Lys) (2 mg/ml) 6.93 ( 95) 
DNA (2 mg/ml) 6.30 ( 86) 
RNA (2 mg/ml) 4.97 ( 68) 
NaCl(O.15 M) 5.85 ( 80) 
Heparin + NaCl 4.23 ( 58) 
Poly(LGlu) + NaCl 0.20 ( 3) 
Dextran sulfate + NaCl 3.38 ( 46) 
Fraction Number 
Fig.2. Elution profile of ornithine decarboxylase from heparin- 
substituted Sepharose. Partially purified ornithine decarboxyl- 
ase (-750 ng protein) was applied to a small heparin-substi- 
tuted Sepharose column (0.1 ml) equilibrated with 10 mM 
sodium phosphate buffer (pH 7 .O) containing 0.1 mM EDTA, 
10 mM 2-mercaptoethanol and 0.1 mM pyridoxal phosphate. 
The column was eluted successively with increasing levels of 
NaCl in the equilibration buffer in 0.2 ml fractions. At the 
points by the arrows, the NaCl level was changed: (1) 25 mM; 
(2) 150 mM; (3) 500 mM. Aliquots of each fraction were 
measured for the ornithine decarboxylase activity (o) and the 
protein concentration (0) as in section 2. 
may be a reversible process. Although the precise role 
of polyanions in modulating ornithine decarboxylase 
in vivo remains unknown, the fact that many tissue 
components, including cell membranes, are polyani- 
onic leads to the speculation that polyanionic com- 
pounds may act as an important factor in the regula- 
tion of biosynthesis of polyamines. 
The reversible binding of ornithine decarboxylase 
to heparin may provide a useful tool for purification 
of the enzyme, since the enzyme preparation in the 
fraction 9 which was eluted with 0.15 M NaCl from 
the column of heparin-substituted Sepharose (fig.2) 
was purified almost 1 O-fold with -80% yield. 
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